TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+0.51%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.57B
AUM Growth
-$21.5M
(-0.83%)
Cap. Flow
+$30M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
39.02%
Holding
198
New
37
Increased
49
Reduced
41
Closed
10
Top Buys
| 1 |
Pfizer
PFE
|
$38.2M |
| 2 |
Johnson & Johnson
JNJ
|
$20.1M |
| 3 |
Esperion Therapeutics
ESPR
|
$13.7M |
| 4 |
Nektar Therapeutics
NKTR
|
$13.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$11.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$34.4M |
| 2 |
Amgen
AMGN
|
$27.5M |
| 3 |
Biogen
BIIB
|
$18.3M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$17.9M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$16.9M |
Sector Composition
| 1 | Healthcare | 93.47% |
| 2 | Real Estate | 2.71% |
| 3 | Financials | 0.31% |
